Latest / Yakima News Today | 2 Min News | The Daily News Now!
BPC-157 in the FDA Spotlight | Yakima News
The FDA is weighing whether compounding pharmacies should be allowed to make BPC-157, a peptide popularized online for pain relief and muscle recovery despite lacking solid human evidence. Though not approved in the U.S., it’s surged in popularity—especially when paired with TB-500 as the “Wolverine stack”—driven by social media hype. A recent advisory panel voted to permit its production, partly influenced by Robert F. Kennedy Jr., but the final decision is pending. New data reveals over 1,000 patients using BPC-157 between 2020 and 2026, mostly for pain or stomach issues, with usage spiking…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.